Linking Nucleoporins, Mitosis, and Colon Cancer

Slides:



Advertisements
Similar presentations
Development of Antibiotic Activity Profile Screening for the Classification and Discovery of Natural Product Antibiotics Weng Ruh Wong, Allen G. Oliver,
Advertisements

Transformation is a multistep process
Cytogenetic and molecular events in adenoma and well-differentiated thyroid follicular- cell neoplasia  Paola Caria, Roberta Vanni  Cancer Genetics and.
How Cholesterol-Dependent Cytolysins Bite Holes into Membranes
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
Polo-like Kinase 4 Inhibition: A Strategy for Cancer Therapy?
Volume 22, Issue 5, Pages v-vi (May 2015)
Macrolactamization of Glycosylated Peptide Thioesters by the Thioesterase Domain of Tyrocidine Synthetase  Hening Lin, Desiree A. Thayer, Chi-Huey Wong,
Metastasis gets site specific
Deubiquitination of Lys63-Linkage by a CYLD UBP
Mechanisms of Chromosomal Instability
Nature’s Strategy for Catalyzing Diels-Alder Reaction
Scratch n’ Screen for Inhibitors of Cell Migration
Matthieu Desroses, Mikael Altun  Cell Chemical Biology 
Ready, Set, Go! How Protein Kinase C Manages Dynamic Signaling
Adding Specificity to Artificial Transcription Activators
Finding the Missing Code of RNA Recognition by PUF Proteins
Personalizing Therapy for Colorectal Cancer
ABT-199: Taking Dead Aim at BCL-2
Saving the Ends for Last: The Role of Pol μ in DNA End Joining
Meiosis: A PRDM9 Guide to the Hotspots of Recombination
Deubiquitination of Lys63-Linkage by a CYLD UBP
Spindle Pole Regulation by a Discrete Eg5-Interacting Domain in TPX2
Volume 4, Issue 1, Pages 4-6 (July 2003)
Remodeling Amyloid Fibers: Baker’s Yeast Shows Us the Way
Targeting the Undruggable Proteome: The Small Molecules of My Dreams
Chromatin Meets Its Organizers
Chemical-Induced Naive Pluripotency
What's so Bor(a)ing about Aurora-A Activation?
Screening Drugs for Kidney Disease: Targeting the Podocyte
Prion-like Domains Program Ewing’s Sarcoma
Kif15 Cooperates with Eg5 to Promote Bipolar Spindle Assembly
PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
Spindle Pole Regulation by a Discrete Eg5-Interacting Domain in TPX2
Activity-Based Profiling for Drug Discovery
Microbes, Microbiota, and Colon Cancer
Plant Stem Cells Current Biology
Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery
PARP Inhibitors in Cancer Therapy: Promise, Progress, and Puzzles
The centrosome Current Biology
Tumor Metabolism: MAGE-A Proteins Help TRIM Turn Over AMPK
Mitosis: Too Much of a Good Thing (Can Be Bad)
Geoffrey J. Guimaraes, Yimin Dong, Bruce F. McEwen, Jennifer G. DeLuca 
Centrosome Size: Scaling Without Measuring
Nuclear Pores Set the Speed Limit for Mitosis
Justin Crest, Kirsten Concha-Moore, William Sullivan  Current Biology 
PLK1 Inhibitors: Setting the Mitotic Death Trap
Nature’s Strategy for Catalyzing Diels-Alder Reaction
L-DOPA Ropes in tRNAPhe
Timothy A. Isgro, Klaus Schulten  Structure 
Harnessing the Antioxidant Power with ARE-Inducing Compounds
Volume 18, Issue 15, Pages R641-R645 (August 2008)
Volume 21, Issue 9, Pages (September 2014)
Volume 21, Issue 7, Pages (July 2014)
Volume 19, Issue 9, Pages R353-R355 (May 2009)
Chemical Inhibitors: The Challenge of Finding the Right Target
Volume 138, Issue 6, Pages (May 2010)
The Ran GTPase: Theme and Variations
The Dynamic Nature of the Nuclear Envelope
Tag-Team SUMO Wrestling
Tools to Tackle Protein Acetylation
Chromothripsis Current Biology
Closed Mitosis: A Timely Move before Separation
Nadine Krüger, Iva M. Tolić-Nørrelykke  Current Biology 
Just the Beginning: Novel Functions for Angiotensin-Converting Enzymes
The NB-ARC domain: a novel signalling motif shared by plant resistance gene products and regulators of cell death in animals  Erik A. van der Biezen,
There's a Time and a Place for MYCN
Hinrich Gronemeyer, Arthur Zelent  Cancer Cell 
Volume 21, Issue 9, Pages (September 2014)
A Wounded Nucleus Needs ESCRT Service
Presentation transcript:

Linking Nucleoporins, Mitosis, and Colon Cancer Richard W. Wong, Maximiliano D’Angelo  Cell Chemical Biology  Volume 23, Issue 5, Pages 537-539 (May 2016) DOI: 10.1016/j.chembiol.2016.05.004 Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 1 From Nucleoporins to Colon Cancer, Via Mitosis (A) A schematic representation of the nuclear pore complex structure Nup358/RanBP2 is colored in red (left). The current mammalian nuclear pore proteins/nucleoporins are Nup358/RanBP2, Nup214, Nup88, NupL2, Gle1, Aladin, Nup62, Nup54, Nup58, Rae1, Nup98, Nup133, Nup160, Nup85, Nup107, Nup96, Seh1, Sec13, ELYS, Nup43, Nup37, Gp210, Ndc1, TMEM33, Pom121, Nup205, Nup188, Nup93, Nup155, Nup35, Tpr, Nup153, and Nup50. The domain organization of full-length human Nup358/RanBP2 is shown on the right. Numbers on the right refer to amino acids. Vertical lines are FG-motifs; Leu-rich, leucine-rich domain; R, Ran-binding domain; E3, E3 ligase domain; Zinc Fingers, zinc finger motifs; and CY, cyclophilin homology domain. (B) A simplified timeline for sporadic colorectal cancer (CRC) pathogenesis. Tumorigenesis can be divided into tumor initiation (development of an adenoma) and tumor progression to malignancy (carcinoma) that can spread as metastasis. BRAF (V600E) is colored in brown. (C) A Model for Nup358/RanBP2 in mitotic progression and faithful chromosomal segregation. The absence of RanBP2/Nup358 during mitosis or vinorelbine treatments causes abnormal mitotic spindles, supernumerary centrosomes, and impaired chromosomal alignment and induces mitotic catastrophe and cell death. Cell Chemical Biology 2016 23, 537-539DOI: (10.1016/j.chembiol.2016.05.004) Copyright © 2016 Elsevier Ltd Terms and Conditions